📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease. (2018)

First Author: Eyers PA

Attributed to: Towards a unifying theory of Parkinson's disease: Investigation of the biochemical and genetic role of Rab GTPases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1042/bcj20170870

PubMed Identifier: 29305429

Publication URI: http://europepmc.org/abstract/MED/29305429

Type: Journal Article/Review

Volume: 475

Parent Publication: The Biochemical journal

Issue: 1

ISSN: 0264-6021